M
Mark J. Rapoport
Researcher at Sunnybrook Health Sciences Centre
Publications - 140
Citations - 3767
Mark J. Rapoport is an academic researcher from Sunnybrook Health Sciences Centre. The author has contributed to research in topics: Poison control & Dementia. The author has an hindex of 32, co-authored 123 publications receiving 3261 citations. Previous affiliations of Mark J. Rapoport include Women's College, Kolkata & University of Toronto.
Papers
More filters
Journal ArticleDOI
The role of the cerebellum in cognition and behavior: A selective review
TL;DR: A selective review of studies assessing potential cognitive deficits and personality changes associated with cerebellar disease and preliminary studies of the role of the cerebellum in schizophrenia, dementia, and other psychiatric disorders are discussed.
Journal ArticleDOI
The Clinical Significance of Major Depression Following Mild Traumatic Brain Injury
TL;DR: The need for the early diagnosis and prompt treatment of major depression following mild traumatic brain injury is highlighted, and major depression is associated with poor outcome across multiple domains.
Journal ArticleDOI
Cognitive Impairment Associated With Major Depression Following Mild and Moderate Traumatic Brain Injury
TL;DR: Subjects with major depression were found to have significantly lower scores on measures of working memory, processing speed, verbal memory and executive function following mild and moderate TBI.
Journal ArticleDOI
Efficacy and feasibility of nonpharmacological interventions for neuropsychiatric symptoms of dementia in long term care: a systematic review.
Dallas Seitz,Sarah Brisbin,Nathan Herrmann,Nathan Herrmann,Mark J. Rapoport,Mark J. Rapoport,Kimberley Wilson,Sudeep S. Gill,Jenna Rines,Ken Le Clair,David K. Conn +10 more
TL;DR: There are several nonpharmacological interventions that may be effective for NPS in LTC, although there are a limited number of large-scale, high-quality studies in this area.
Journal ArticleDOI
Efficacy and safety of antidepressants for treatment of depression in Alzheimer's disease: a metaanalysis.
TL;DR: Antidepressant treatment for depression in AD is efficacious, with rates of discontinuation that are comparable to placebo, Nonetheless, clinicians must be vigilant regarding the potential side effects of antidepressants in this population.